Soluble-type small-molecule CD4 mimics as HIV entry inhibitors.
Bioorg Med Chem Lett
; 29(5): 719-723, 2019 03 01.
Article
en En
| MEDLINE
| ID: mdl-30665681
ABSTRACT
Several small molecule CD4 mimics have been reported previously as HIV-1 entry inhibitors, which block the interaction between the Phe43 cavity of HIV-1 gp120 and the host CD4. Known CD4 mimics such as NBD-556 possess significant anti-HIV activity but are less soluble in water, perhaps due to their hydrophobic aromatic ring-containing structures. Compounds with a pyridinyl group in place of the phenyl group in these molecules have been designed and synthesized in an attempt to increase the hydrophilicity. Some of these new CD4 mimics, containing a tetramethylpiperidine ring show significantly higher water solubility than NBD-556 and have high anti-HIV activity and synergistic anti-HIV activity with a neutralizing antibody. The CD4 mimic that has a cyclohexylpiperidine ring and a 6-fluoropyridin-3-yl ring has high anti-HIV activity and no significant cytotoxicity. The present results will be useful in the future design and development of novel soluble-type molecule CD4 mimics.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Antígenos CD4
/
VIH-1
/
Imitación Molecular
/
Inhibidores de Fusión de VIH
/
Bibliotecas de Moléculas Pequeñas
Límite:
Humans
Idioma:
En
Año:
2019
Tipo del documento:
Article